SCHEMBL6164630

SCHEMBL6164630

O=C1CCc2c1c(-c1cnc3ccccc3n1)nn2CCO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
BCHE P06276 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
KDM4E B2RXH2 5/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 5/20 0.34
RAB9A P51151 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
GAA P10253 2/20 0.34
CASP1 P29466 1/20 0.34
MAPK10 P53779 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
JAK3 P52333 2/20 0.34
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163581 0.86 CYP1A2 (0.36) KMT2AMEN1KDM4EALDH1A1MAPT
SCHEMBL6164169 0.78 HTT (0.48) HTTKMT2AMEN1KDM4EALDH1A1
SCHEMBL6166822 0.74 HTT (0.44) HTTKMT2AMEN1KDM4EALDH1A1
SCHEMBL6167339 0.72 HTT (0.45) HTTHSP90AA1HSP90AB1KMT2AMEN1
SCHEMBL6166050 0.72 HTT (0.47) HTTALDH1A1MAPK10
SCHEMBL6161914 0.71 HTT (0.44) HTTKMT2AMEN1KDM4EALDH1A1
SCHEMBL6162358 0.71 HTT (0.46) HTTKMT2AMEN1KDM4EALDH1A1
SCHEMBL6164980 0.69 HTT (0.44) HTT
SCHEMBL6164117 0.69 HTT (0.46) HTTKMT2AMEN1MAPTHPGD
SCHEMBL6164255 0.68 HTT (0.46) HTTKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed